1. Home
  2. LGVN vs NURO Comparison

LGVN vs NURO Comparison

Compare LGVN & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • NURO
  • Stock Information
  • Founded
  • LGVN 2014
  • NURO 1996
  • Country
  • LGVN United States
  • NURO United States
  • Employees
  • LGVN N/A
  • NURO N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • NURO Medical/Dental Instruments
  • Sector
  • LGVN Health Care
  • NURO Health Care
  • Exchange
  • LGVN Nasdaq
  • NURO Nasdaq
  • Market Cap
  • LGVN 31.2M
  • NURO 7.7M
  • IPO Year
  • LGVN 2021
  • NURO N/A
  • Fundamental
  • Price
  • LGVN $3.19
  • NURO $3.69
  • Analyst Decision
  • LGVN Strong Buy
  • NURO
  • Analyst Count
  • LGVN 1
  • NURO 0
  • Target Price
  • LGVN $12.00
  • NURO N/A
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • NURO 7.8K
  • Earning Date
  • LGVN 08-09-2024
  • NURO 07-29-2024
  • Dividend Yield
  • LGVN N/A
  • NURO N/A
  • EPS Growth
  • LGVN N/A
  • NURO N/A
  • EPS
  • LGVN N/A
  • NURO N/A
  • Revenue
  • LGVN $978,000.00
  • NURO $5,270,210.00
  • Revenue This Year
  • LGVN $137.24
  • NURO N/A
  • Revenue Next Year
  • LGVN $50.77
  • NURO N/A
  • P/E Ratio
  • LGVN N/A
  • NURO N/A
  • Revenue Growth
  • LGVN N/A
  • NURO N/A
  • 52 Week Low
  • LGVN $0.77
  • NURO $2.70
  • 52 Week High
  • LGVN $35.60
  • NURO $7.92
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 55.13
  • NURO 52.32
  • Support Level
  • LGVN $2.90
  • NURO $3.65
  • Resistance Level
  • LGVN $4.88
  • NURO $3.80
  • Average True Range (ATR)
  • LGVN 0.70
  • NURO 0.15
  • MACD
  • LGVN 0.01
  • NURO 0.02
  • Stochastic Oscillator
  • LGVN 34.66
  • NURO 46.67

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: